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MicroRNAs are a class of non-coding RNAs and the dysregulated expression of these
short RNA molecules was frequently observed in cancer cells. The steady state level of
microRNA concentration may differentiate the biological function of the cells between
normal and impaired. To understand the steady state or equilibrium of microRNAs, their
interactions with transcription factors and target genes need to be explored and visualized
through prediction and network analysis algorithms.This article discusses the application
of mathematical model for simulating the dynamics of network feedback loop so as to
decipher the mechanism of microRNA regulation.
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REGULATORY FUNCTIONS OF microRNAs
MicroRNAs (miRNAs) constitute a set of non-coding RNAs that
are short in length, around 21–25 nucleotides, and endoge-
nous. Protein expression is repressed or the coding message
is degraded when miRNAs are bound to the 3-untranslated
regions (UTRs) of the target messenger RNAs (mRNAs) with
imperfect complementarity (Baek et al., 2008). In mammals,
over 800 miRNAs have been identiﬁed and those are capa-
ble to simultaneously regulate hundreds to thousands of genes
and thus their biological networks (Wu et al., 2009). It was
reportedthatmiR-7downregulatessigniﬁcantlytheEGFR expres-
sion in various malignancies, including glioblastoma, breast can-
cer, prostate cancer, and lung cancer (Webster et al., 2009). This
ﬁnding was further conﬁrmed by the miR-7 target prediction
using TargetScan, an in silico analysis pipeline. Through the
prediction, three putative target sites at the 3-UTR of EGFR
transcript were identiﬁed and two of them ranked very high
due to the fact that they are proximal to AU-rich sequences.
Indeed, diminished EGFR expression leads to the cell cycle arrest
and the cell growth reduction. It was also shown that multi-
ple associated members of EGFR downstream signaling pathway
were regulated by miR-7 in cancer cell lines, including pro-
tein kinase B and extracellular signal-regulated kinase (ERK) 1/2
(Webster et al., 2009).
A miRNA could regulate the expression of hundreds of
genes. The proteins expressed from these genes targeted by
a particular miRNA tend to be hubs and bottlenecks in the
protein interactions network (Hsu et al., 2008). The biolog-
ical functions of this speciﬁc subset of proteins are thus
altered by an individual miRNA. Conversely, a gene could
be a common target of many miRNAs. A systematic search
performed at 10 representative resources, including prediction
pipelines and curated databases as listed in Table 1, revealed
that 138 miRNAs potentially target EGFR transcript accord-
ing to various identiﬁcation criteria. In this set of poten-
tial miRNAs, 25 of them were predicted by at least 3
prediction pipelines and conﬁrmed by at least 1 curated database
(Chan et al., 2011). This observation implicated a comprehensive
post-transcriptionalregulatorynetworkmediatedbymiRNAsbut
the underlying mechanism and conditions of the gene regulation
by miRNAs is still unclear.
TRANSCRIPTIONAL REGULATION OF miRNA EXPRESSION
Dysregulation of miRNA expression have long been hypothe-
sized as the pathogenesis of cancers. The stimulation of miR-7
expression in an ERK suggested that miR-7 expression is pro-
moted by EGFR through the Ras/ERK/Myc signaling cascade,
which is found in the non-small cell lung cancer (NSCLC)
pathway (Chou et al., 2010). Most of the miRNAs are tran-
scribed in independent units, which are distant from the anno-
tated genes (Bartel, 2004). Such miRNAs have their own pro-
moter regions where the transcription factors (TFs) regulate their
expression via TF binding sites (TFBS) within the promoter
region of miRNA genes. Some of the miRNAs are processed
from the introns of the protein coding genes. The expression
of this class of miRNAs is regulated by the TFs via TFBS at
the promoter region of the host gene of the miRNAs. Pub-
lic database has been developed for modeling the interactions
between TFs and TFBSs (Matys et al., 2003). TFBSs are usu-
ally organized in DNA footprints, called cis-regulatory modules
(CRMs). CRMs are featured by the evolutionary conservation of
the TFBS sequences and the co-expression of the corresponding
TFs (Blanchette et al., 2006). A TF is predicted when the cor-
responding TFBS(s) are found within the upstream 5kbp of a
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Table 1 | Ten representative resources for in silico miRNA target
identiﬁcation.
Resource Type Website
DIANA-microT Prediction http://diana.cslab.ece.ntua.gr/microT/
MicroCosm-targets Prediction http://www.ebi.ac.uk/enright-srv/ micro-
cosm/htdocs/targets/v5/
miRWalk-predicted Prediction http://www.umm.uni-heidelberg.de/
apps/zmf/mirwalk/
TargetScan Prediction http://www.targetscan.org/
miRanda-mirSVR Prediction http://www.microrna.org/
miRDB Prediction http://mirdb.org/miRDB/
PicTar Prediction http://pictar.mdc-berlin.de/
PITA Prediction http://genie.weizmann.ac.il/pubs/mir07/
miR2Disease Curated http://mlg.hit.edu.cn:8080/miR2Disease
miRWalk-validated Curated http://www.umm.uni-heidelberg.de/
apps/zmf/mirwalk/
miRNA gene or within the promoter region of the host gene
(Yu et al., 2008). Such predictions implicate higher complexity
and variability in the regulatory network topology as miRNAs are
not only regulators of protein expression but also regulated by
proteins. Feedback loops (FBLs) become frequently observed
patterns in the gene regulatory networks.
GENOME-WIDE miRNA REGULATION ANALYSIS
Biological processes are typically regulated by the dynamic inter-
actions of biomolecules and genetic materials, including genes,
TFs, and miRNAs, between or within the living cells, due to
the cell cycle or the external stress. Regulatory networks pro-
vide framework for understanding the cascade of these molec-
ular interactions and exploring the biologically relevant motifs.
The alteration of these molecular interaction networks leads to
localized or systemic malignancy in living organisms, especially
human sapiens. Many computational algorithms and databases
have been developed for generating and analyzing comprehen-
sive models of the regulatory interactions at genome-wide scale
(Su et al., 2010; Béchec et al., 2011). In those resources, miR-
NAs are regarded as a class of key actors interplaying with the
other key actors, such as genes and TFs. Network motifs with the
enrichment of gene ontology (GO) could give insight into the
underlying biological functions performed by the “teamwork” of
these actors.
FEEDBACK LOOP FOR miRNA HOMEOSTASIS
Many miRNAs are related to cancer pathogenesis and thus
regarded as “onco-miRs.” The over-expressions of such miRNAs
werefrequentlyobservedincancercelllines.Conversely,thereexist
cancer suppressor miRNAs that post-transcriptionally repress
the expression of oncogenes and their under-expressions were
also found in cancer cells. Therefore, the ﬂuctuation in miRNA
expression level does not favor the normal biological processes.
It is still unclear how the steady state of miRNA expression
is achieved.
The expression of miR-591 was found in colorectal tumor cells
but not in the normal cells through miRNA serial analysis of gene
expression (miRAGE; Cummins et al., 2006). It is meaningful to
decipher the mechanism, under which the miRNAs expression is
maintained at a low level in the normal cells. MiRNA and TF
analysis network (MIR@NT@N) was used to predict the TFs and
gene targets of miR-591 and to construct the regulatory network
among them (Béchec et al., 2011). Nine TFs were found with full
score. More interestingly, the algorithm predicts the gene expres-
sionsof twoof theseTFsarerepressedbymiR-591.Theregulatory
network of miR-591 is shown in Figure 1. MZF1 and FOXA1 are
two TFs, which regulate miR-591, but their gene expressions are
also repressed by miR-591. These reciprocal interactions, high-
lighted in the right-top box of Figure 1, are referred to as FBLs
of biological systems. The balance between miR-591, MZF1, and
FOXA1 can be automatically attained through the FBLs. Further,
MZF1 is also the TF of the other TFs of miR-591 except FOXL1.
Thus,theretardedexpressionof MZF1willalsosuppressthetran-
scription of miR-591 indirectly. Such direct and indirect FBLs
may explain why and how onco-miR expression level is low in
normal cells.
FIGURE 1 | Regulatory network of miR-591 generated by MIR@NT@N
(Béchec et al., 2011).
Mathematical modeling could be applied to elucidate the
reciprocal regulatory responses of the actors in the FBLs. The
state-space model was used to simulate the concentrations and
their rates of a panel of TFs (Yu et al., 2008). As miRNAs are
also key actors of the regulation, the TFs and miRNAs could
constitute the state vector of the model so to understand the
homeostasis of miRNA expression in normal cells and the effect
of perturbed miRNA expression in cancer cells with the future
research endeavors.
CONCLUSION
Based on the identiﬁed feedback mechanism, differential equa-
tion system can be established to model biological programs
contributed by miRNAs. The response of miRNA expression
due to the dysregulation of interacting genes can be simulated
using the model, providing useful information for therapeutic
planning.
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